Reliant Announces FDA Clearance of Its Fraxel Laser

Reliant Technologies announced that the FDA has granted 510(k) market approval of the Fraxel laser for skin resurfacing procedures, providing physicians a gentle and intelligent treatment approach to fast, remarkable results with minimal downtime and maximum safety.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050330005219&newsLang=en)